Literature DB >> 7238269

Syndromatic hepatic ductular hypoplasia (arteriohepatic dysplasia): a clinical and hepatic histologic study of three patients.

M D Berman, K G Ishak, E J Schaefer, S Barnes, E A Jones.   

Abstract

Clinical and pathologic features of three patients with chronic intrahepatic cholestasis from birth are described. Each patient exhibited a paucity and hypoplasia of interlobular bile ducts, unusual facies, short stature, a pulmonary ejection systolic murmur, and structural anomalies of vertebrae. This constellation of defects constitutes a distinct syndrome to which the terms arteriohepatic dysplasia and syndromatic hepatic ductular hypoplasia are applied. Clinically, cholestasis was not progressive and, although the SGPT was chronically elevated (122--520 units/liter), features of liver cell failure did not develop. Changes in plasma lipids and lipoproteins and serum bile acids were consistent with chronic cholestasis. Liver biopsies from the three cases revealed pseudoxanthomatous change, increased stainable copper and mild hepatocellular degenerative changes. Electron microscopy of one of the liver biopsies revealed extension of thick bundles of collagen from portal areas into hepatic lobules with obliteration of the space of Mall. With increasing age, portal tracts contained fewer bile ducts. This apparent progression of the lesion was not associated with an inflammatory cell infiltrate, progressive fibrosis, or the development of cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7238269     DOI: 10.1007/bf01308096

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  24 in total

Review 1.  Cholestasis in the first three months of life.

Authors:  D Alagille
Journal:  Prog Liver Dis       Date:  1979

2.  Determination of human serum lipoprotein patterns by agarose gel electrophoresis.

Authors:  N M Papadopoulos; J A Kintzios
Journal:  Anal Biochem       Date:  1969-09       Impact factor: 3.365

3.  Arteriohepatic dysplasia: familial pulmonary arterial stenosis with neonatal liver disease.

Authors:  G H Watson; V Miller
Journal:  Arch Dis Child       Date:  1973-06       Impact factor: 3.791

4.  Hereditary cholestasis combined with peripheral pulmonary stenosis and other anomalies.

Authors:  N T Henriksen; F Langmark; S J Sorland; O Fausa; S Landaas; O Aagenaes
Journal:  Acta Paediatr Scand       Date:  1977-01

5.  Cholestyramine therapy in patients with a paucity of intrahepatic bile ducts.

Authors:  H L Sharp; J B Carey; J G White; W Krivit
Journal:  J Pediatr       Date:  1967-11       Impact factor: 4.406

6.  Intrahepatic cholestasis in childhood.

Authors:  J Heathcote; K P Deodhar; P J Scheuer; S Sherlock
Journal:  N Engl J Med       Date:  1976-10-07       Impact factor: 91.245

7.  Phenobarbital effects in cholestatic liver diseases.

Authors:  J R Bloomer; J L Boyer
Journal:  Ann Intern Med       Date:  1975-03       Impact factor: 25.391

8.  Efficacy and safety of long-term phenobarbital therapy of familial cholestasis.

Authors:  C N Ghent; J R Bloomer; Y E Hsia
Journal:  J Pediatr       Date:  1978-07       Impact factor: 4.406

9.  The significance of variations in the distribution of copper in liver disease.

Authors:  S Goldfischer; H Popper; I Sternlieb
Journal:  Am J Pathol       Date:  1980-06       Impact factor: 4.307

10.  Liver copper levels in intrahepatic cholestasis of childhood.

Authors:  J Evans; S Newman; S Sherlock
Journal:  Gastroenterology       Date:  1978-11       Impact factor: 22.682

View more
  7 in total

Review 1.  Alagille syndrome.

Authors:  I D Krantz; D A Piccoli; N B Spinner
Journal:  J Med Genet       Date:  1997-02       Impact factor: 6.318

Review 2.  Neonatal obstructive cholangiopathy.

Authors:  D K Bhasin; S Mehta
Journal:  Indian J Pediatr       Date:  1984 Jan-Feb       Impact factor: 1.967

3.  Paucity of interlobular bile ducts: getting to know it better.

Authors:  J Perrault
Journal:  Dig Dis Sci       Date:  1981-06       Impact factor: 3.199

Review 4.  The Alagille syndrome (arteriohepatic dysplasia).

Authors:  R F Mueller
Journal:  J Med Genet       Date:  1987-10       Impact factor: 6.318

5.  Deleted chromosome 20 from a patient with Alagille syndrome isolated in a cell hybrid through leucine transport selection: study of three candidate genes.

Authors:  J F Deleuze; S Dhorne; J Hazan; E Borghi; N Raynaud; N Pollet; M Meunier-Rotival; J Deschatrette; D Alagille; M Hadchouel
Journal:  Mamm Genome       Date:  1994-11       Impact factor: 2.957

6.  Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling.

Authors:  Luca Fabris; Massimiliano Cadamuro; Maria Guido; Carlo Spirli; Romina Fiorotto; Michele Colledan; Giuliano Torre; Daniele Alberti; Aurelio Sonzogni; Lajos Okolicsanyi; Mario Strazzabosco
Journal:  Am J Pathol       Date:  2007-06-28       Impact factor: 4.307

7.  Novel rhein-phospholipid complex targeting skin diseases: development, in vitro, ex vivo, and in vivo studies.

Authors:  Heba M K Ebada; Maha M A Nasra; Yosra S R Elnaggar; Ossama Y Abdallah
Journal:  Drug Deliv Transl Res       Date:  2021-06       Impact factor: 4.617

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.